FastPack Total PSA Immunoassay Chemilunescence assay for the determination of Total PSA. FastPack Total PSA Immunoassay is a paramagnetic particle immunoassay for the in vitro quantitative determination of prostate-specific antigen (PSA) in human serum and plasma as an aid in the management of patients with prostate cancer. The FastPack Total PSA Immunoassay is designed for use with the FastPack System.
Published December 25, 2013 · Recall initiated: November 8, 2013
Summary
FDA records medical device Class II recall Z-0547-2014, published December 25, 2013 and initiated November 8, 2013. Recalling firm: Qualigen Inc; Status: Terminated; Reported quantity: 182; Lot: Total PSA: Catalog Number 25000040. Lot Number 1309038-10P Exp Date 6/26/2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Qualigen initiated this recall because the FastPack kit may cause lower than expected results due to a manufacturing defect.
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Qualigen Inc
- Distributor
- US Distribution to states of: AL, CA, KS, KY, IN, MA, NC, NY, NV, OK, SC, TN, TX, UT, VA, and WA.
- Lot
- Total PSA: Catalog Number 25000040. Lot Number 1309038-10P Exp Date 6/26/2013.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAThe FastPack IP Sex Hormone Binding Globulin Immunoassay, Part #25000081, is for the quantitative measurementJanuary 15, 2025
- FDAFastPack TSH Calibrator Kit, REF: 25000024, For use in conjunction with the FastPack IP TSH Immunoassay andOctober 16, 2024
- FDAQualigen(R) The FastPack(R) IP Vitamin D Complete Immunoassay Kit, catalog number 25000068 Vitamin DSeptember 13, 2017
- FDAFastPack Free T4 Immunoassay FastPack Vitamin D Immunoassay Chemilunescence assay for the determination ofDecember 25, 2013
- FDAContinuous Peripheral Nerve Block Catheter Kit and Set Continuous Peripheral Nerve Block Catheter Kit and SetDecember 25, 2013
- FDAFastPack Testosterone Immunoassay Chemilunescence assay for the determination of Testosterone The FastPackDecember 25, 2013
Questions about this recall
Was FastPack Total PSA Immunoassay Chemilunescence assay for the determination of Total PSA. FastPack Total PSA Immunoassay is a paramagnetic particle immunoassay for the in vitro quantitative determination of prostate-specific antigen (PSA) in human serum and plasma as an aid in the management of patients with prostate cancer. The FastPack Total PSA Immunoassay is designed for use with the FastPack System. recalled?
Yes. FDA published recall Z-0547-2014 on December 25, 2013. Reported hazard: Qualigen initiated this recall because the FastPack kit may cause lower than expected results due to a manufacturing defect.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone